nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—MMP9—bone cancer	0.596	1	CbGaD
Minocycline—SLC22A11—Methotrexate—bone cancer	0.0546	0.34	CbGbCtD
Minocycline—SLC22A7—Methotrexate—bone cancer	0.0521	0.324	CbGbCtD
Minocycline—SLC22A8—Methotrexate—bone cancer	0.0318	0.198	CbGbCtD
Minocycline—SLC22A6—Methotrexate—bone cancer	0.0221	0.138	CbGbCtD
Minocycline—IL1B—knee—bone cancer	0.00978	0.106	CbGeAlD
Minocycline—IL1B—periosteum—bone cancer	0.00673	0.0728	CbGeAlD
Minocycline—MMP9—periosteum—bone cancer	0.00561	0.0607	CbGeAlD
Minocycline—IL1B—vertebral column—bone cancer	0.00558	0.0603	CbGeAlD
Minocycline—IL1B—leg—bone cancer	0.00537	0.0581	CbGeAlD
Minocycline—IL1B—forelimb—bone cancer	0.00533	0.0576	CbGeAlD
Minocycline—CASP3—appendage—bone cancer	0.00515	0.0557	CbGeAlD
Minocycline—IL1B—hindlimb—bone cancer	0.00479	0.0519	CbGeAlD
Minocycline—IL1B—cartilage tissue—bone cancer	0.00472	0.051	CbGeAlD
Minocycline—IL1B—appendage—bone cancer	0.00411	0.0445	CbGeAlD
Minocycline—MMP9—hindlimb—bone cancer	0.00399	0.0432	CbGeAlD
Minocycline—MMP9—cartilage tissue—bone cancer	0.00393	0.0425	CbGeAlD
Minocycline—MMP9—appendage—bone cancer	0.00343	0.0371	CbGeAlD
Minocycline—CASP1—connective tissue—bone cancer	0.00178	0.0193	CbGeAlD
Minocycline—CYCS—connective tissue—bone cancer	0.00171	0.0186	CbGeAlD
Minocycline—CASP3—connective tissue—bone cancer	0.00147	0.0159	CbGeAlD
Minocycline—CASP1—tendon—bone cancer	0.00122	0.0133	CbGeAlD
Minocycline—CASP1—bone marrow—bone cancer	0.00119	0.0128	CbGeAlD
Minocycline—CASP1—spinal cord—bone cancer	0.00118	0.0128	CbGeAlD
Minocycline—IL1B—connective tissue—bone cancer	0.00117	0.0127	CbGeAlD
Minocycline—CYCS—bone marrow—bone cancer	0.00114	0.0124	CbGeAlD
Minocycline—CYCS—spinal cord—bone cancer	0.00114	0.0123	CbGeAlD
Minocycline—Rolitetracycline—CYP3A4—bone cancer	0.00105	0.528	CrCbGaD
Minocycline—CASP3—tendon—bone cancer	0.00101	0.0109	CbGeAlD
Minocycline—CASP3—bone marrow—bone cancer	0.000978	0.0106	CbGeAlD
Minocycline—MMP9—connective tissue—bone cancer	0.000978	0.0106	CbGeAlD
Minocycline—CASP3—spinal cord—bone cancer	0.000974	0.0105	CbGeAlD
Minocycline—IL1B—tendon—bone cancer	0.000807	0.00873	CbGeAlD
Minocycline—VEGFA—tendon—bone cancer	0.000793	0.00858	CbGeAlD
Minocycline—IL1B—bone marrow—bone cancer	0.000781	0.00845	CbGeAlD
Minocycline—IL1B—spinal cord—bone cancer	0.000778	0.00842	CbGeAlD
Minocycline—ALOX5—connective tissue—bone cancer	0.000773	0.00837	CbGeAlD
Minocycline—VEGFA—bone marrow—bone cancer	0.000769	0.00832	CbGeAlD
Minocycline—VEGFA—spinal cord—bone cancer	0.000765	0.00828	CbGeAlD
Minocycline—MMP9—tendon—bone cancer	0.000672	0.00727	CbGeAlD
Minocycline—MMP9—bone marrow—bone cancer	0.000651	0.00704	CbGeAlD
Minocycline—MMP9—spinal cord—bone cancer	0.000648	0.00701	CbGeAlD
Minocycline—ALOX5—bone marrow—bone cancer	0.000515	0.00557	CbGeAlD
Minocycline—Tetracycline—CYP3A4—bone cancer	0.000481	0.242	CrCbGaD
Minocycline—Doxycycline—CYP3A4—bone cancer	0.000456	0.23	CrCbGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bone cancer	0.000187	0.00126	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000186	0.00125	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—RB1—bone cancer	0.000186	0.00125	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—JUN—bone cancer	0.000186	0.00125	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP9—bone cancer	0.000186	0.00125	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—TP53—bone cancer	0.000179	0.0012	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—TP53—bone cancer	0.000176	0.00119	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—MDM2—bone cancer	0.000174	0.00117	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NT5C3A—bone cancer	0.000174	0.00117	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL3—bone cancer	0.000173	0.00116	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—JUN—bone cancer	0.000172	0.00116	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—TP53—bone cancer	0.000172	0.00115	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000172	0.00115	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000172	0.00115	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—MMP2—bone cancer	0.000171	0.00115	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by TCPTP—EGFR—bone cancer	0.000171	0.00115	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—JUN—bone cancer	0.000171	0.00115	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—PTGS2—bone cancer	0.000169	0.00114	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000169	0.00113	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—JUN—bone cancer	0.000168	0.00113	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000168	0.00113	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—SPARC—bone cancer	0.000168	0.00113	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—JUN—bone cancer	0.000166	0.00112	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—MMP2—bone cancer	0.000164	0.0011	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CDK4—bone cancer	0.000164	0.0011	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—bone cancer	0.000163	0.0011	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—PTGS2—bone cancer	0.000163	0.0011	CbGpPWpGaD
Minocycline—SLC22A7—Fluoropyrimidine Activity—TP53—bone cancer	0.000162	0.00109	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—TP53—bone cancer	0.000162	0.00109	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000161	0.00108	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000161	0.00108	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—JUN—bone cancer	0.00016	0.00108	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—ATF1—bone cancer	0.000159	0.00107	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000158	0.00106	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—BRAF—bone cancer	0.000158	0.00106	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000156	0.00105	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—TP53—bone cancer	0.000156	0.00105	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—JUN—bone cancer	0.000155	0.00104	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—TP53—bone cancer	0.000154	0.00104	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000154	0.00104	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDK4—bone cancer	0.000154	0.00103	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000153	0.00103	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—TP53—bone cancer	0.000153	0.00103	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000153	0.00103	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—PTGS2—bone cancer	0.000153	0.00103	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—JUN—bone cancer	0.000151	0.00102	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—EGFR—bone cancer	0.000151	0.00102	CbGpPWpGaD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—TP53—bone cancer	0.000151	0.00101	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—MMP9—bone cancer	0.000148	0.000996	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000146	0.000982	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—MMP9—bone cancer	0.000146	0.000979	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TP53—bone cancer	0.000145	0.000974	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—bone cancer	0.000144	0.00097	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000144	0.000967	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—BRAF—bone cancer	0.000143	0.000959	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—RB1—bone cancer	0.000143	0.000959	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP2—bone cancer	0.000142	0.000958	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000139	0.000935	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000139	0.000934	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TP53—bone cancer	0.000139	0.000932	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—EGFR—bone cancer	0.000136	0.000912	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MMP9—bone cancer	0.000134	0.000902	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—KIT—bone cancer	0.000134	0.0009	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—RB1—bone cancer	0.000134	0.000899	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—EZH2—bone cancer	0.000132	0.000891	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—EGFR—bone cancer	0.000132	0.00089	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—bone cancer	0.000132	0.000887	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—EGFR—bone cancer	0.000131	0.000879	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000131	0.000878	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—JUN—bone cancer	0.00013	0.000873	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NDUFA12—bone cancer	0.000129	0.000868	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—EGFR—bone cancer	0.000127	0.000856	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP53—bone cancer	0.000127	0.000854	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—IGF1R—bone cancer	0.000126	0.000849	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000126	0.000848	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TP53—bone cancer	0.000125	0.000843	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000125	0.000841	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TP53—bone cancer	0.000124	0.000832	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—JUN—bone cancer	0.000122	0.000819	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	0.000121	0.000813	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00012	0.000807	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—EGFR—bone cancer	0.00012	0.000805	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000119	0.000801	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—PTGS2—bone cancer	0.000117	0.000788	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000117	0.000786	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000115	0.000773	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—JUN—bone cancer	0.000115	0.000772	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—MDM2—bone cancer	0.000114	0.000767	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.000111	0.000745	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—JUN—bone cancer	0.00011	0.000741	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—bone cancer	0.00011	0.000738	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—KIT—bone cancer	0.00011	0.000737	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000109	0.000732	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—EGFR—bone cancer	0.000108	0.000729	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP9—bone cancer	0.000107	0.00072	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NT5C3A—bone cancer	0.000107	0.000719	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000106	0.000713	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—bone cancer	0.000106	0.000713	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—MDM2—bone cancer	0.000105	0.000709	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—JUN—bone cancer	0.000104	0.000699	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000104	0.000697	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP2—bone cancer	0.000103	0.000696	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000103	0.000696	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—GSTP1—bone cancer	0.000103	0.000694	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—BRAF—bone cancer	0.000103	0.000692	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000102	0.000684	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—bone cancer	0.000101	0.000676	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—bone cancer	0.0001	0.000673	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—bone cancer	9.99e-05	0.000672	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—JUN—bone cancer	9.91e-05	0.000666	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—EGFR—bone cancer	9.83e-05	0.000661	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—bone cancer	9.76e-05	0.000656	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—MET—bone cancer	9.73e-05	0.000654	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	9.69e-05	0.000651	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—bone cancer	9.62e-05	0.000647	CbGpPWpGaD
Minocycline—CASP1—Immune System—ATF1—bone cancer	9.26e-05	0.000623	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.15e-05	0.000615	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—bone cancer	9.1e-05	0.000612	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—KIT—bone cancer	9.05e-05	0.000608	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL3—bone cancer	9.03e-05	0.000607	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—EGFR—bone cancer	9.02e-05	0.000607	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.84e-05	0.000595	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MDM2—bone cancer	8.67e-05	0.000583	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SPARC—bone cancer	8.64e-05	0.000581	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—MDM2—bone cancer	8.63e-05	0.00058	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—BRAF—bone cancer	8.61e-05	0.000579	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—EGFR—bone cancer	8.31e-05	0.000559	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—bone cancer	8.25e-05	0.000555	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—EGFR—bone cancer	8.17e-05	0.000549	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	8.14e-05	0.000548	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—bone cancer	8.08e-05	0.000543	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RGS1—bone cancer	7.96e-05	0.000535	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GRM4—bone cancer	7.96e-05	0.000535	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—GNA11—bone cancer	7.9e-05	0.000532	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—bone cancer	7.78e-05	0.000523	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.63e-05	0.000513	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ENO2—bone cancer	7.6e-05	0.000511	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—bone cancer	7.58e-05	0.000509	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—JUN—bone cancer	7.53e-05	0.000507	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDK4—bone cancer	7.48e-05	0.000503	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—JUN—bone cancer	7.34e-05	0.000494	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MET—bone cancer	7.31e-05	0.000492	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—EGFR—bone cancer	7.21e-05	0.000485	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP2—bone cancer	7.18e-05	0.000483	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	7.18e-05	0.000483	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL3—bone cancer	7.17e-05	0.000482	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MDM2—bone cancer	7.13e-05	0.000479	CbGpPWpGaD
Minocycline—CYCS—Metabolism—DHFR—bone cancer	7.05e-05	0.000474	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—bone cancer	6.98e-05	0.000469	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	6.92e-05	0.000466	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GRM1—bone cancer	6.9e-05	0.000464	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—bone cancer	6.86e-05	0.000461	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	6.84e-05	0.00046	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GNA11—bone cancer	6.59e-05	0.000443	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—bone cancer	6.54e-05	0.00044	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—RB1—bone cancer	6.5e-05	0.000437	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MET—bone cancer	6.35e-05	0.000427	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—JUN—bone cancer	6.27e-05	0.000422	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	6.24e-05	0.00042	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—JUN—bone cancer	6.19e-05	0.000417	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MMP2—bone cancer	6.1e-05	0.00041	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP3A4—bone cancer	5.97e-05	0.000402	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—bone cancer	5.92e-05	0.000398	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—bone cancer	5.9e-05	0.000396	CbGpPWpGaD
Minocycline—IL1B—Immune System—ATF1—bone cancer	5.79e-05	0.000389	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL3—bone cancer	5.64e-05	0.00038	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MDM2—bone cancer	5.54e-05	0.000373	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RGS1—bone cancer	5.52e-05	0.000372	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GRM4—bone cancer	5.52e-05	0.000372	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP2—bone cancer	5.29e-05	0.000356	CbGpPWpGaD
Minocycline—CASP1—Immune System—KIT—bone cancer	5.27e-05	0.000354	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MET—bone cancer	5.22e-05	0.000351	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CDK4—bone cancer	5.22e-05	0.000351	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTP1—bone cancer	5.11e-05	0.000344	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—bone cancer	4.97e-05	0.000334	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—bone cancer	4.93e-05	0.000331	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.91e-05	0.00033	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—bone cancer	4.87e-05	0.000327	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SMO—bone cancer	4.86e-05	0.000327	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—JUN—bone cancer	4.82e-05	0.000324	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GRM4—bone cancer	4.8e-05	0.000323	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RGS1—bone cancer	4.8e-05	0.000323	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GRM1—bone cancer	4.79e-05	0.000322	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PLAU—bone cancer	4.7e-05	0.000316	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ENO2—bone cancer	4.68e-05	0.000315	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MET—bone cancer	4.53e-05	0.000305	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CDK4—bone cancer	4.53e-05	0.000305	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNA11—bone cancer	4.45e-05	0.000299	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—bone cancer	4.35e-05	0.000293	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—DHFR—bone cancer	4.35e-05	0.000292	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GRM1—bone cancer	4.16e-05	0.00028	CbGpPWpGaD
Minocycline—CASP1—Immune System—MDM2—bone cancer	4.15e-05	0.000279	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ATF1—bone cancer	4.13e-05	0.000278	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	4.12e-05	0.000277	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GNA11—bone cancer	4.06e-05	0.000273	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL3—bone cancer	4.03e-05	0.000271	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—bone cancer	3.98e-05	0.000268	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—bone cancer	3.78e-05	0.000254	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—bone cancer	3.7e-05	0.000249	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP3A4—bone cancer	3.68e-05	0.000248	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.66e-05	0.000246	CbGpPWpGaD
Minocycline—CASP1—Immune System—JUN—bone cancer	3.61e-05	0.000243	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFBR2—bone cancer	3.45e-05	0.000232	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMO—bone cancer	3.38e-05	0.000227	CbGpPWpGaD
Minocycline—IL1B—Immune System—KIT—bone cancer	3.29e-05	0.000221	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1R—bone cancer	3.24e-05	0.000218	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—bone cancer	3.22e-05	0.000216	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—bone cancer	3.18e-05	0.000214	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTP1—bone cancer	3.15e-05	0.000212	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNA11—bone cancer	3.09e-05	0.000208	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMO—bone cancer	2.93e-05	0.000197	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ATF1—bone cancer	2.87e-05	0.000193	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—bone cancer	2.84e-05	0.000191	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—bone cancer	2.84e-05	0.000191	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL3—bone cancer	2.8e-05	0.000188	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNA11—bone cancer	2.68e-05	0.00018	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—bone cancer	2.65e-05	0.000178	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—bone cancer	2.64e-05	0.000178	CbGpPWpGaD
Minocycline—IL1B—Immune System—MDM2—bone cancer	2.59e-05	0.000174	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ATF1—bone cancer	2.49e-05	0.000168	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL3—bone cancer	2.43e-05	0.000163	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFBR2—bone cancer	2.39e-05	0.000161	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KIT—bone cancer	2.35e-05	0.000158	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—bone cancer	2.29e-05	0.000154	CbGpPWpGaD
Minocycline—IL1B—Immune System—JUN—bone cancer	2.25e-05	0.000152	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1R—bone cancer	2.25e-05	0.000151	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BRAF—bone cancer	2.21e-05	0.000149	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFBR2—bone cancer	2.08e-05	0.00014	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1R—bone cancer	1.95e-05	0.000131	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—bone cancer	1.89e-05	0.000127	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MDM2—bone cancer	1.85e-05	0.000125	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—bone cancer	1.77e-05	0.000119	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KIT—bone cancer	1.63e-05	0.00011	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—bone cancer	1.63e-05	0.00011	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—JUN—bone cancer	1.61e-05	0.000108	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—bone cancer	1.57e-05	0.000105	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BRAF—bone cancer	1.54e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KIT—bone cancer	1.42e-05	9.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BRAF—bone cancer	1.33e-05	8.96e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MDM2—bone cancer	1.29e-05	8.65e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—bone cancer	1.27e-05	8.52e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—JUN—bone cancer	1.12e-05	7.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MDM2—bone cancer	1.12e-05	7.51e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—bone cancer	1.06e-05	7.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—JUN—bone cancer	9.71e-06	6.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—bone cancer	9.44e-06	6.35e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—bone cancer	8.79e-06	5.91e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—bone cancer	7.63e-06	5.13e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—bone cancer	7.38e-06	4.96e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—bone cancer	6.41e-06	4.31e-05	CbGpPWpGaD
